Somatuline Depot 90mg (Lanreotide PFS) 90MG PFS 0.2 ML

SOMATULINE DEPOT 90MG (lanreotide) is a prescription injectable used for hormone-related conditions. Store between 2-8°C and protect from light. This long-acting somatostatin analog helps manage symptoms in broad therapeutic categories. Suitable for patients requiring sustained-release formulations.

Strength

90MG PFS 0.2 ML

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Ipsen Biopharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Lanreotide 90mg is used to address hormone-related symptoms in conditions like acromegaly and neuroendocrine tumors. It helps reduce growth hormone and insulin-like growth factor levels. Patients may use it for symptom control when other treatments are insufficient. This medication is typically administered by healthcare professionals.

Side Effects

Common effects include mild injection site reactions such as pain or swelling. Some patients report gastrointestinal discomfort like nausea or diarrhea. These effects are usually temporary and vary by individual. Regular monitoring may help manage any persistent issues.

Precautions & Warnings

Keep SOMATULINE DEPOT refrigerated between 2-8°C and avoid freezing. Protect from light by storing in original packaging. Do not use if the solution is discolored or contains particles. Always follow healthcare provider instructions for handling and disposal.

Avoid Interactions

Lanreotide may interact with medications affecting heart rhythm or blood sugar levels. Caution is advised when combining with drugs metabolized by CYP enzymes. Alcohol use may enhance certain side effects. Always disclose all medications to your healthcare provider before starting treatment.

Frequently Asked Questions

It is used to manage symptoms of hormone-related conditions such as acromegaly and neuroendocrine tumors.

This medication is typically given as an injection by a healthcare professional every 28 days.

No, it must be refrigerated between 2-8°C and protected from light.

Common side effects include injection site reactions and mild gastrointestinal discomfort.

It may interact with drugs affecting heart rhythm or blood sugar levels; consult your healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.